IN THE NEWS

THE LATEST NEWS

Meet us at J.P.Morgan Healthcare Conference

Partner of Choice: Aitia and Servier Revolutionize the Landscape of Pancreatic Cancer Treatment

Charles River and Aitia Join Forces to Harness AI and Gemini Digital Twins in Advancing Neurodegenerative and Oncology Research

Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology

SfN Poster | Genes regulating cytoskeleton organization identified as neuro-common drivers of blood NfL change rate and disease-specific clinical progression in AI driven Digital Twins

Cytoskeleton Genes Underlying Onset and Progression in Multiple Neurodegenerative Disorders Discovered through Aitia’s Digital Twins to be Presented at SfN 2023

Driving the Discovery and Clinical Development of the Next Generation of Alzheimer’s Disease Drugs: Join us at the CNS Summit 2023

CTAD Poster | Prediction of Amyloid PET positivity from blood-based biomarkers and clinical data using AI-based Digital Twins

Prediction of Amyloid PET Positivity from Blood-Based Biomarkers, Proteomics, and Clinical Data Discovered through Aitia’s Digital Twins to be Presented at CTAD 2023

Prediction of Amyloid PET Positivity from Blood-Based Biomarkers, Proteomics, and Clinical Data Discovered through Aitia’s Digital Twins to be Presented at CTAD 2023